A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.

MLA

Feinberg, J. E., et al. “A Randomized, Double-Blind Trial of Valaciclovir Prophylaxis for Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.” The Journal of Infectious Diseases, vol. 177, no. 1, Jan. 1998, pp. 48–56. EBSCOhost, https://doi.org/10.1086/513804.

APA

Feinberg, J. E., Hurwitz, S., Cooper, D., Sattler, F. R., MacGregor, R. R., Powderly, W., Holland, G. N., Griffiths, P. D., Pollard, R. B., Youle, M., Gill, M. J., Holland, F. J., Power, M. E., Owens, S., Coakley, D., Fry, J., & Jacobson, M. A. (1998). A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group. The Journal of Infectious Diseases, 177(1), 48–56. https://doi.org/10.1086/513804

Chicago

Feinberg, J E, S Hurwitz, D Cooper, F R Sattler, R R MacGregor, W Powderly, G N Holland, et al. 1998. “A Randomized, Double-Blind Trial of Valaciclovir Prophylaxis for Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.” The Journal of Infectious Diseases 177 (1): 48–56. doi:10.1086/513804.